December 28, 2017 / 12:02 PM / 20 days ago

BRIEF-Jubilant Pharma Updates On USFDA Approval For Draximage® Dtpa​

Dec 28 (Reuters) - Jubilant Pharma Ltd (IPO-JUBI.SI):

    * ‍JUBILANT RECEIVES SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA​ Source text for Eikon: Further company coverage:

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below